AdaptHealth Corp vs Quantumscape Corp — how do they compare? AdaptHealth Corp trades at $5.67 (market cap $753.09M), while Quantumscape Corp trades at $6.51 (market cap $3.90B). The key difference: Quantumscape Corp is far larger — about 5.2× AdaptHealth Corp's market cap. Which is the better fit depends on your goals.
| AHCO | QS | |
|---|---|---|
Market Cap | $753.09M | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $18.44 |
52-Week Low | $5.22 | $4.89 |
Enterprise Value | $2.77B | $3.11B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QuantumScape (QS) trades at $6.19, up 1.89% today, with a mixed technical outlook showing bullish oscillators but bearish moving averages. The company remains pre-revenue with significant losses, reporting a net income of -$435.05M in 2025 (company filing, 2025). Recent Q2 2026 earnings beat expectations but highlighted ongoing commercialization delays, with solid-state battery targets pushed to 2029 (The Motley Fool, 2026-08-11).
The stock presents high-risk speculation due to zero revenue and persistent cash burn, offset by potential long-term disruption in battery technology. Analyst sentiment is cautious with 73% hold ratings, reflecting skepticism on near-term execution. Key risks include timeline slippage, funding needs, and competitive pressure in the EV supply chain.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →